News


2022-01-16 14:20:05 | 87
COVID-19: Thousands to take part in trial of game-changing coronavirus pill molnupiravir that can be taken at home

Molnupiravir is the first of several antiviral treatments that will be tested during the study, which is being led by the University of Oxford.


A nationwide trial of a "game-changing" antiviral pill for vulnerable people who test positive for coronavirus is now under way.

Molnupiravir is the first of several antiviral treatments that will be tested during the study, which is being led by the University of Oxford.

The trial is aiming to recruit 10,600 people to test whether the pill reduces the need for the over 50s and those with underlying health problems to be admitted to hospital.

Those who take part in the trial, which has been named PANORAMIC, will have to have tested positive following a PCR test.

Participants will have to complete a daily diary for 28 days through the trial's website, or receive a phone call from the trial team on days days seven, 14 and 28 to speak about their symptoms.

The first set of results from the trial are anticipated in early 2022.

Those at highest risk who test positive for the coronavirus - for example, people who are immunocompromised, certain cancer patients or those with Down's syndrome - will be able to access either Ronapreve, an antibody treatment which is taken through an IV infusion in hospital or one of the new COVID Medicines Delivery Units (CMDUs), or molnupiravir, from 16 December.

news source

https://news.sky.com/story/covid-19-thousands-to-take-part-in-trial-of-game-changing-coronavirus-pill-molnupiravir-that-can-be-taken-at-home-12490154


TESTIMONIALS